© 2002 by European Society of Cardiology
Copyright © 2002, European Society of Cardiology
Hormones, genetic factors, and gender differences in cardiovascular disease
Women's Health Initiative, National Heart, Lung and Blood Institute, 1 Rockledge Center, Suite 300, 6705 Rockledge Drive, Bethesda, MD 20892-7966, USA
* Tel.: +1-301-435-6669; fax: +1-301-480-5158 rossouwj@nih.gov
Received 6 July 2001; accepted 30 August 2001
KEYWORDS Gender; Gene therapy
| The first 150 words of the full text of this article appear below. |
| 1. Gender differences in age of onset of coronary heart disease |
|---|
On average, women develop heart disease some 10–15 years later than men. This raises the question of whether there is some aspect of femaleness which reduces risk, or whether there is some aspect of maleness that raises risk. To date, most attention has been focused on the hypothesis that endogenous estrogen is cardioprotective in women [1]. Rising rates of coronary heart disease (CHD) after the menopause, and after oophorectomy, are among the strands of evidence in humans that endogenous estrogen may prevent CHD [2]. However, upon closer examination this evidence is not persuasive, and in fact the evidence is amenable to alternative explanations.
During the first 3 decades of adult life, low-density lipoprotein (LDL) cholesterol levels are lower in women than men, and this may contribute to the delayed onset of CHD in women. A more widely held explanation for the later onset of CHD in women is
| 2. Observational studies of estrogen users |
|---|
| 3. Biological mechanisms for cardioprotection by estrogen |
|---|
| 4. Genetic mechanisms for cardioprotection by estrogen |
|---|
| 5. Evidence of early harm from clinical trials |
|---|
| 6. Mechanisms for explaining an increased risk for arterial disease shortly after commencing HRT |
|---|
| 7. Conclusions |
|---|
This article has been cited by other articles:
![]() |
M. E. Reichelt, L. Willems, B. A. Hack, J. N. Peart, and J. P. Headrick Cardiac and coronary function in the Langendorff-perfused mouse heart model Exp Physiol, January 1, 2009; 94(1): 54 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Boron, N. A. Turiano, S. L. Willis, and K. W. Schaie Effects of Cognitive Training on Change in Accuracy in Inductive Reasoning Ability J. Gerontol. B. Psychol. Sci. Soc. Sci., May 1, 2007; 62(3): P179 - P186. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Deschepper and B. Llamas Hypertensive Cardiac Remodeling in Males and Females: From the Bench to the Bedside Hypertension, March 1, 2007; 49(3): 401 - 407. [Full Text] [PDF] |
||||
![]() |
F. Fantin, A. Mattocks, C. J. Bulpitt, W. Banya, and C. Rajkumar Is augmentation index a good measure of vascular stiffness in the elderly? Age Ageing, January 1, 2007; 36(1): 43 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hoffmann, S. Moebus, A. Stang, E.-M. Beck, N. Dragano, S. Mohlenkamp, A. Schmermund, M. Memmesheimer, K. Mann, R. Erbel, et al. Residence close to high traffic and prevalence of coronary heart disease Eur. Heart J., November 2, 2006; 27(22): 2696 - 2702. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wang, P. Crisostomo, G. M. Wairiuko, and D. R. Meldrum Estrogen receptor-{alpha} mediates acute myocardial protection in females Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2204 - H2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Z. Ring, C. N. Lessov, T. Reed, R. Marcus, L. Holloway, G. E. Swan, and D. Carmelli Heritability of Plasma Sex Hormones and Hormone Binding Globulin in Adult Male Twins J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3653 - 3658. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Costanza, E. Cayanis, B. M. Ross, M. S. Flaherty, G. B. Alvin, K. Das, and A. Morabia Relative Contributions of Genes, Environment, and Interactions to Blood Lipid Concentrations in a General Adult Population Am. J. Epidemiol., April 15, 2005; 161(8): 714 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsuda, M. Iwai, J.-M. Li, H.-S. Li, L.-J. Min, A. Ide, M. Okumura, J. Suzuki, M. Mogi, H. Suzuki, et al. Inhibitory Effects of AT1 Receptor Blocker, Olmesartan, and Estrogen on Atherosclerosis Via Anti-Oxidative Stress Hypertension, April 1, 2005; 45(4): 545 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Nguyen, D. R. Liles, P. H. Lin, and R. L. Bush Hormone Replacement Therapy and Peripheral Vascular Disease in Women Vascular and Endovascular Surgery, November 1, 2004; 38(6): 547 - 556. [Abstract] [PDF] |
||||
![]() |
P H Wirtz, R von Kanel, N Rohleder, and J E Fischer Monocyte proinflammatory cytokine release is higher and glucocorticoid sensitivity is lower in middle aged men than in women independent of cardiovascular risk factors Heart, August 1, 2004; 90(8): 853 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Morabia, E. Cayanis, M. C. Costanza, B. M. Ross, M. S. Flaherty, G. B. Alvin, K. Das, and T. C. Gilliam Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors Hum. Mol. Genet., November 1, 2003; 12(21): 2733 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mehilli, A. Kastrati, H. Bollwein, A. Dibra, H. Schuhlen, J. Dirschinger, and A. Schomig Gender and restenosis after coronary artery stenting Eur. Heart J., August 2, 2003; 24(16): 1523 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shimoni and X.-F. Liu Sex differences in the modulation of K+ currents in diabetic rat cardiac myocytes J. Physiol., July 15, 2003; 550(2): 401 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y. Liu, A. K. Death, and D. J. Handelsman Androgens and Cardiovascular Disease Endocr. Rev., June 1, 2003; 24(3): 313 - 340. [Abstract] [Full Text] [PDF] |
||||












